Home Search
vaccine - search results
If you're not happy with the results, please do another search
Study says 0.0006% chance of myocarditis as COVID vaccine side effect
According to a study with 2,392,924 participants, acute myocarditis is an extremely rare side effect of the COVID vaccine - at 0.0006% likelihood.
NIH funds menstrual cycle and COVID vaccine research
McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
FDA approves Pfizer booster vaccine for over 65s
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
COVID-19 vaccines: Risks versus benefits
Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.
Do breastfeeding mothers have COVID vaccine side effects?
Researchers found that breastfeeding mothers and their infants faced no significant COVID vaccine side effects from the Pfizer and Moderna vaccines.
Scientists begin work on COVID vaccines which can survive heat
Scientists at the University of California San Diego are developing COVID vaccines that can survive heat - using ideas from plants and bacteria.
WHO leader says “there is no vaccine for the climate crisis”
A new editorial, published across 220 journals, expresses the climate concerns of healthcare professionals and researchers - with Dr Ghebreyesus saying "there is no vaccine for the climate crisis".
EU and AstraZeneca agree new deadline for vaccine deliveries
The EU have dropped their court case against AstraZeneca, as a new deadline for vaccine deliveries is agreed between the two parties.
Why are young people in the UK vaccine hesitant?
ONS data finds that young people are distrustful of the vaccine, the UK Government, and anyone encouraging vaccine take-up - alongside the perception that COVID will not threaten their lives.
EU medical authority denies “urgent need” for third dose of COVID vaccine
The European Centre for Disease Prevention and Control (ECDC) reports that there is no "urgent need" for a third dose of COVID vaccine, based on real-world data
According to the report published Wednesday (1 September), there is enough real-world evidence to suggest that a booster dose is not yet necessary.
The...
Real-world study on 800,000 vaccinated people says COVID vaccine safe
An ongoing real-world study on the Israeli population finds that the Pfizer COVID vaccine is safe to use - minimal side effects were observed in over 800,000 people.
Research says COVID vaccines work for 90% of immunosuppressed people
New research finds that COVID vaccines work for 90% of people who are currently immunosuppressed due to their medication.
Malaria deaths reduced by 70% with vaccine and drug combination
A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.
Five new research projects will examine COVID-19 vaccine responses
Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.
Immunocompromised patients show low immune response after second vaccine
According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.
Clinical trial to test third COVID-19 vaccine for people with weakened immune systems
A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.
UK orders 35 million more Pfizer/BioNTech vaccine doses
The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..
FDA gives full approval to Pfizer COVID vaccine
The US Food and Drug Administration fully approved the Pfizer COVID vaccine - meaning that it is now permanently approved for use in those aged 16 and over.
Study warns “vaccine nationalism” will create more COVID variants
Global "vaccine nationalism" is the dominant approach to the virus so far - but according to researchers at Princeton and McGill University, this mentality increases the chances of a new variant.
Moderna create vaccine trial for children aged 6 months and over
Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.
